Senkyunolide A ameliorates cholestatic liver fibrosis by controlling CLCC1-mediated endoplasmic reticulum Ca(2+) release.

Senkyunolide A 通过控制 CLCC1 介导的内质网 Ca(2+) 释放来改善胆汁淤积性肝纤维化。